🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, open-label, multi-center seamless phase II to phase ...
Status
Recruiting
Location
VA Long Beach Healthcare System, Long Beach, CA
Start Date
2021-07-01
Trial ID
NCT04787744
Treatments Being Tested
The purpose of this study is to determine if apalutamide plus gonadotropin ...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-11-19
Trial ID
NCT02531516
Single-arm, single site, open label study of the effects of parenteral test...
Status
Completed
Location
Sibley Memorial Hospital
Start Date
2014-08-25
Trial ID
NCT02090114
Treatments Being Tested
This trial is going to evaluate tumor control and quality of life in patien...
Status
Unknown
Location
Tianjin Medical University Cancer Hospital
Start Date
2015-11
Trial ID
NCT02605226
This phase II trial tests how well pembrolizumab along with standard of car...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-16
Trial ID
NCT06528210
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. A...
Status
Unknown
Location
UAB Comprehensive Cancer Center
Start Date
2008-02
Trial ID
NCT00567580
Treatments Being Tested
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androge...
Status
Completed
Location
Providence Cancer Center
Start Date
2006-09-26
Trial ID
NCT00309985
Treatments Being Tested
The aim of this study is to determine the long term effects of two types of...
Status
Completed
Location
Wirral University Hospitals NHS Trust
Start Date
1999-10
Trial ID
NCT00536653
This is a prospective phase II study to assess the efficacy and toxicity of...
Status
Recruiting
Location
Houston Methodist Hospital
Start Date
2018-08-02
Trial ID
NCT03541928
The aim of this study is to test whether adding chemotherapy/cabazitaxel an...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2012-05
Trial ID
NCT01531205